Literature DB >> 24694476

Prevalence and characteristics of headaches in a socially active population working in the Tokyo metropolitan area -surveillance by an industrial health consortium.

Norihiro Suzuki1, Yoshiki Ishikawa, Shintaro Gomi, Nobuhiko Ito, Shigeru Watanabe, Masako Yokoyama, Kazuo Funatsu, Hitoshi Miyake, Hirokazu Yokoyama, Toshihiko Shimizu, Mamoru Shibata.   

Abstract

OBJECTIVE: The goal of this study was to determine the prevalence and clinical characteristics of headaches among socially active people working in the Tokyo metropolitan area.
METHODS: We cross-sectionally surveyed 7,917 individuals. The survey assessed demographic characteristics, the prevalence and characteristics of headaches and physician attendance.
RESULTS: The lifetime prevalence of migraines was 8.9%, while that of tension-type headaches was 14.7%. Women exhibited a higher prevalence of migraines than men (15% vs. 3.7%; p<0.001). The prevalence of migraines and tension-type headaches differed among occupations. Susceptibility to migraines and tension-type headaches related to working overtime was observed. With respect to the influence of migraines on social activities, 22.4% of the migraineurs had been obliged to miss work due to headaches several times a year. As many as 59.4% of the sufferers had never consulted a physician about their headaches. Moreover, 24.6% of the migraineurs were not in touch with any physician at the time of the survey. The most common reason why they had stopped visiting their physician was that they had been told their headaches were not fatal.
CONCLUSION: Migraines adversely affect social activities. These data provide important information for understanding the features of migraines and tension-type headaches in socially active people working in the Tokyo metropolitan area.

Entities:  

Mesh:

Year:  2012        PMID: 24694476     DOI: 10.2169/internalmedicine.53.1700

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  6 in total

Review 1.  Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature.

Authors:  Takao Takeshima; Qi Wan; Yanlei Zhang; Mika Komori; Serina Stretton; Narayan Rajan; Tamas Treuer; Kaname Ueda
Journal:  J Headache Pain       Date:  2019-12-05       Impact factor: 7.277

2.  Social burden of people with the migraine diagnosis in Japan: evidence from a population-based cross-sectional survey.

Authors:  Hisaka Igarashi; Kaname Ueda; Sungeun Jung; Zhihong Cai; Yirong Chen; Tomomi Nakamura
Journal:  BMJ Open       Date:  2020-11-09       Impact factor: 2.692

3.  Preliminary development of a deep learning-based automated primary headache diagnosis model using Japanese natural language processing of medical questionnaire.

Authors:  Masahito Katsuki; Norio Narita; Yasuhiko Matsumori; Naoya Ishida; Ohmi Watanabe; Siqi Cai; Teiji Tominaga
Journal:  Surg Neurol Int       Date:  2020-12-29

4.  Questionnaire-Based Survey during COVID-19 Vaccination on the Prevalence of Elderly's Migraine, Chronic Daily Headache, and Medication-Overuse Headache in One Japanese City-Itoigawa Hisui Study.

Authors:  Masahito Katsuki; Junko Kawahara; Yasuhiko Matsumori; Chinami Yamagishi; Akihito Koh; Shin Kawamura; Kenta Kashiwagi; Tomohiro Kito; Akio Entani; Toshiko Yamamoto; Miyako Otake; Takashi Ikeda; Fuminori Yamagishi
Journal:  J Clin Med       Date:  2022-08-11       Impact factor: 4.964

5.  Multinational descriptive analysis of the real-world burden of headache using the Migraine Buddy application.

Authors:  Peter J Goadsby; Luminita Constantin; Caty Ebel-Bitoun; Iva Igracki Turudic; Simon Hitier; Caroline Amand-Bourdon; Andrew Stewart
Journal:  Eur J Neurol       Date:  2021-08-28       Impact factor: 6.288

6.  Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city-Itoigawa study.

Authors:  Masahito Katsuki; Chinami Yamagishi; Yasuhiko Matsumori; Akihito Koh; Shin Kawamura; Kenta Kashiwagi; Tomohiro Kito; Akio Entani; Toshiko Yamamoto; Takashi Ikeda; Fuminori Yamagishi
Journal:  Neurol Sci       Date:  2022-01-19       Impact factor: 3.830

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.